Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generics
Pharma
Hefty sales of generics boost Teva to another big quarter
Teva revealed booming third-quarter sales for its generics, with U.S. revenue from the knockoffs reaching $1.1 billion, which was a 30% increase.
Kevin Dunleavy
Nov 6, 2024 3:19pm
Exelixis stock rises as Cabometyx withstands patent challenge
Oct 16, 2024 10:37am
Health plan sues Biogen for alleged Tecfidera kickbacks scheme
Aug 21, 2024 11:34am
Novartis doubles down in Entresto defense with FDA complaint
Aug 1, 2024 5:34pm
Senate unanimously passes bill targeting 'patent thickets'
Jul 12, 2024 9:28am
Drug shortages lasting longer, driven by economic issues: report
Jun 5, 2024 9:40am
